STAT3 and mature T-cell and NK-cell non-Hodgkin lymphoma: However, the reported mutation frequency does not represent widespread STAT3 activation found in PTCL patients, which highlights the need to identify additional mechanisms of STAT3 deregulation in PTCL subtypes.